Company Overview and News

Stocks edge up from 2-week low in thin trade

Sri Lankan shares inched slightly higher yesterday from a two-week closing low, but foreign selling amid political uncertainty weighed on trade, stockbrokers said. The Colombo stock index ended 0.08 percent firmer at 6,557.02, edging up from its lowest close since February 14 hit on Wednesday. Sri Lankan markets were closed for a holiday on Thursday. The index fell 0.28 percent this week.

Sri Lanka shares end near 9-mth low; foreign selling in Keells weighs

2017-01-04 lankabusinessonline
Jan 04, 2017 (Reuters) – Sri Lankan shares fell for a fourth straight session on Wednesday, to end at a near nine-month low, as investors sold large-cap shares on fears that continued foreign selling in John Keells Holdings could dampen market sentiment further.

Teejay Lanka replaces Ceylinco Insurance in new S&P SL20 rebalance

2016-12-15 lankabusinessonline
Dec 15, 2016 (LBO) – Colombo Stock Exchange today announced changes to the S&P Sri Lanka 20 index made by S&P Dow Jones Indices at the 2016 annual index rebalance.

Ceylinco Insurance PLC Rings Opening Bell for October

Ceylinco Insurance PLC rang the Opening Bell to commence trading at the Colombo Stock Exchange (CSE) for the month of October and outlined the company’s commitment to contribute towards the sustainable growth of the economy and country.

Sri Lankan stocks post 3-month closing high in high turnover

Reuters – Aug 23 Sri Lankan shares ended marginally higher on Tuesday and posted their highest close in three months, led by financials while turnover hit a 4-1/2-month high on expectations of better economic performance after the government said it would achieve its revenue target for this year.

‘Ransalu Pranama’ privilege card received by 13,000 odd Omega Line Group employees

‘Ransalu Pranama’ privilege debit card, exclusively for the benefit of apparel industry employee was launched at the Cinnamon Grand Hotel recently. The official event was graced by Hon. Rishad Bathiudeen, the Minister of Industry and Commerce and Hon. Ravi Karunanayake, the Finance Minister. The event organized by Joint Apparel Associations Forum (JAAF), CH 17 and Commercial Bank, saw a cross section of apparel industry employees from the fraternity receiving their privilege cards as a symbolic gesture.

Sri Lankan shares fall for 5th day on rising interest rates

Reuters – Sri Lankan shares fell for a fifth straight session on Friday and posted their lowest close in five weeks, as rising interest rates and lack of new catalysts dented investor sentiment.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...